-
DNase I (RNase-free): From Clean RNA to Rigor
2026-09-18
DNA carryover is not a minor cleanup issue in RNA research; it can distort reverse-transcription assays, obscure transcript integrity, and weaken translational decisions. This thought-leadership article explains how DNase I (RNase-free) can be deployed as a strategically controlled preanalytical step across RNA extraction, in vitro transcription, chromatin studies, and long self-amplifying RNA quality assessment.
-
A-1331852: BCL-XL Inhibitor Workflow
2026-09-18
A-1331852 is a potent, selective BCL-XL inhibitor for linking target engagement with mitochondrial apoptosis in cancer research. This practical guide covers compound handling, apoptosis assay design, BCL-XL–BIM complex disruption, combination studies, and troubleshooting for reproducible preclinical workflows.
-
Berberine Hydrochloride: AMPK Assay Workflows
2026-09-17
Build reproducible Berberine hydrochloride workflows for AMPK signaling, LDL receptor regulation, lipid metabolism modulation, and cancer assays. This guide translates a cardiotoxicity study into practical assay design while separating evidence-backed findings from exploratory recommendations.
-
Short-Scale BIR Amplifies DNA Damage in Oocytes
2026-09-17
The reference study identifies short-scale break-induced replication (ssBIR) as a DNA synthesis response to double-strand breaks in fully grown mouse oocytes. Its combination of EdU labeling, damage-marker analysis, developmental-stage comparison, and replication-pathway inhibitors supports a model in which Rad51-dependent repair can amplify, rather than simply resolve, DNA damage.
-
Chloroquine Diphosphate in Ferroptosis Assays
2026-09-16
Build more informative cancer research workflows with Chloroquine Diphosphate as an autophagy, TLR7/TLR9, and cell-cycle perturbation tool. This guide shows how to pair it with orthogonal ferroptosis readouts, chemotherapy sensitization studies, and disciplined troubleshooting without mistaking autophagic flux changes for proof of cell death.
-
TAI-1: A Mechanistic Map of Hec1 Inhibition
2026-09-15
TAI-1 is a first-in-class Hec1 inhibitor that converts mitotic checkpoint disruption into a tractable cancer research strategy. This article distinguishes Hec1-driven mitotic stress from WEE1-associated transcription–replication damage and develops an assay framework for interpreting selectivity, synergy, and biomarker response.
-
Entinostat (MS-275): Practical HDAC1/3 Assays
2026-09-15
Build sharper epigenetic experiments with Entinostat (MS-275), from solvent-controlled cancer cell assays to time-resolved regeneration studies. This workflow separates HDAC target engagement, growth arrest, apoptosis induction, and tissue-level phenotypes instead of treating viability loss as a single endpoint.
-
Müller Cell PEDF Controls Retinal Neuron Survival
2026-09-14
The reference study identifies Müller cell-derived pigment epithelium-derived factor (PEDF) as a key intermediary linking angiopoietin balance to retinal neuronal survival through Tie-2–PI3K/Akt signaling. Its co-culture, knockdown, and rescue experiments provide a useful framework for studying neurovascular interactions under hypoxic stress.
-
FK866 (APO866) Workflow for NAMPT Research
2026-09-14
FK866 (APO866) enables controlled investigation of NAMPT-dependent NAD depletion, with practical applications spanning hematologic cancer research, mitochondrial injury, and pathway validation. This workflow emphasizes dose finding, orthogonal metabolic readouts, and careful interpretation of caspase-independent cell death rather than relying on viability data alone.
-
Recombinant Mouse IFN-γ for MASH-HCC Assays
2026-09-13
Use Recombinant Mouse IFN-γ as a controlled immune-pressure variable when testing how bile acid retention affects tumor-cell antigen presentation. This workflow separates cytokine responsiveness from the GPR120–bile acid–NLRC5 mechanism and adds practical controls for reproducible immunometabolic research.
-
Fenipentol: From Chuanxiong Signal to Assay
2026-09-12
Fenipentol and 1-Phenyl-1-pentanol connect Chuanxiong metabolomics with practical gastrointestinal, hepatobiliary, and receptor-focused research. This article explains how to translate differential volatile-component data into better assay controls, interpretation, and experimental design.
-
Meropenem Trihydrate: Designing Resistance Assays
2026-09-12
Meropenem trihydrate can serve not only as a carbapenem antibiotic reference but also as a controlled perturbation in resistance research. This guide translates LC-MS/MS metabolomics findings into practical assay design, interpretation, and infection-model decisions.
-
AMG 487: A Context-Aware CXCR3 Antagonist
2026-09-11
AMG 487 is a potent CXCR3 antagonist that can separate receptor-dependent signaling from state-dependent macrophage behavior. This guide connects its pharmacology, assay design, metabolism, and the CXCL10-CXCR3-LAMP1 findings to more rigorous inflammation research.
-
pH-Responsive siRNA Targeting Glioblastoma
2026-09-11
Su and colleagues developed a cRGD-PEG-siEGFR conjugate that combines integrin-directed uptake, acid-responsive behavior, and improved circulation to address delivery barriers in glioblastoma. The study reports selective uptake and EGFR silencing in αvβ3-positive U87MG cells, antitumor activity, and lower renal accumulation than an earlier cRGD-siRNA construct, while also identifying important translational limitations.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-10
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1215, provides fluorescent detection of goat IgG primary antibodies in ICC/IF, tissue staining, flow cytometry, and ELISA workflows. It should not be used with non-goat primary antibodies without validation, and assay-specific dilution, blocking, instrument settings, and matrix compatibility must be established experimentally.